Related Experiment Video

Updated: May 5, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

14.4K

Recent Advances in the Treatment of ST-Segment Elevation Myocardial Infarction

Mun K Hong1

  • 1Cardiac Catheterization Laboratory and Interventional Cardiology, St. Luke's-Roosevelt Hospital Center, 1111 Amsterdam Avenue, New York, NY 10025, USA ; Columbia University College of Physicians and Surgeons, 630 W. 168th St., New York, NY 10032, USA.

Scientifica
|November 27, 2013
PubMed

Insights

ST-segment elevation myocardial infarction (STEMI) is a critical heart condition. Advances in angioplasty and medications improve survival, with ongoing efforts focused on faster treatment and future stem cell therapies.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Regenerative Medicine

Background:

  • ST-segment elevation myocardial infarction (STEMI) is a life-threatening emergency in coronary artery disease.
  • Timely diagnosis and intervention are crucial for improving patient survival and long-term outcomes.
  • Recent therapeutic advancements have positively impacted acute results for STEMI patients.

Purpose of the Study:

  • To review the current management strategies for STEMI.
  • To highlight recent technological and pharmacological advancements in STEMI treatment.
  • To discuss future directions in STEMI research, including stem cell therapy.

Main Methods:

  • Review of current literature on STEMI diagnosis and treatment.
  • Analysis of recent innovations in interventional cardiology devices (stents, aspiration catheters).
  • Evaluation of advancements in pharmacologic therapies (antiplatelets, anticoagulants).

Main Results:

  • Primary angioplasty with stents is the cornerstone of STEMI reperfusion therapy.
  • Drug-eluting stents and potent pharmacologic agents have significantly improved acute outcomes.
  • Reduced door-to-balloon times and public education remain critical for better results.

Conclusions:

  • Current therapeutic strategies have substantially improved STEMI patient outcomes.
  • Continued focus on rapid treatment protocols and public awareness is essential.
  • Autologous stem cell therapy shows promise for restoring left ventricular function and improving long-term quality of life.

More Related Videos

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

4.0K
Intramyocardial Cell Delivery: Observations in Murine Hearts08:12

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

13.1K

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
525
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
954
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
495
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
450
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747